Retraction of “Pharmaco-Technical Evaluation of Statistically Formulated and Optimized Dual Drug-Loaded Silica Nanoparticles for Improved Antifungal Efficacy and Wound Healing”
Key Points
The retraction addresses concerns regarding the data integrity of the dual drug-loaded silica nanoparticles.
Key issues related to the reported antifungal efficacy and wound healing capabilities were highlighted.
Evaluation included a pharmaco-technical review of the formulations and their therapeutic potential.
Potential application limitations are underscored due to the retraction, impacting future antifungal research directions.
Abstract
This retracts the article DOI: 10.1021/acsomega.0c06242..
Retraction of “Pharmaco-Technical Evaluation of Statistically Formulated and Optimized Dual Drug-Loaded Silica Nanoparticles for Improved Antifungal Efficacy and Wound Healing” | Synapse